IR@PKUHSC  > 北京大学药学院
学科主题药学
A new triterpenoid saponin and two neolignans from Ligularia veitchiana
Zhu, H; Tu, PF
关键词Ligularia Veitchiana Liguveitoside b Neolignan Saponin
刊名ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES
2004-09-01
59期:9页:1063-1066
收录类别SCI ; IC
文章类型Article
WOS标题词Science & Technology
类目[WOS]Chemistry, Inorganic & Nuclear ; Chemistry, Organic
研究领域[WOS]Chemistry
关键词[WOS]CONSTITUENTS ; ROOTS ; SESQUITERPENES ; GLYCOSIDES
英文摘要

Phytochemical investigation of the rhizomes and roots of Ligularia veitchiana afforded a new triterpenoid saponin and two known neolignans named liguveitoside B (1), citrusin A (2) and citrusin B (3), respectively. This is the first demonstration of the occurrence of a 8-O-4′ neolignan and the second report on the isolation of triterpenoid saponin in the genus Ligularia. Their structures were elucidated on the basis of spectral data, particularly HSQC, HMBC and NOE experiments. Compound 1 exhibited weak cytotoxicity against a human acute promyelocytic leukemia cell-line (HL-60).

语种英语
WOS记录号WOS:000224377300020
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/57341
专题北京大学药学院
作者单位Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Beijing 100083, Peoples R China
推荐引用方式
GB/T 7714
Zhu, H,Tu, PF. A new triterpenoid saponin and two neolignans from Ligularia veitchiana[J]. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES,2004,59(9):1063-1066.
APA Zhu, H,&Tu, PF.(2004).A new triterpenoid saponin and two neolignans from Ligularia veitchiana.ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES,59(9),1063-1066.
MLA Zhu, H,et al."A new triterpenoid saponin and two neolignans from Ligularia veitchiana".ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES 59.9(2004):1063-1066.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhu, H]的文章
[Tu, PF]的文章
百度学术
百度学术中相似的文章
[Zhu, H]的文章
[Tu, PF]的文章
必应学术
必应学术中相似的文章
[Zhu, H]的文章
[Tu, PF]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。